Positive and Negative Syndrome Scale and High-Density Lipoprotein Cholesterol Levels

Arneil Sitepu

doi:10.37287/ijghr.v6iS6.5255

Arneil Sitepu Institut Kesehatan Deli Husada Deli Tua

DOI: https://doi.org/10.37287/ijghr.v6iS6.5255

Keywords: HDL-C level, PANSS, schizophrenia

Abstract

Schizophrenia is a chronic psychopathological disorder characterized by distortions in cognition, emotion, perception, and behavior. In addition, patients with schizophrenia have a higher risk of cardiometabolic problems, such as obesity, type 2 diabetes, hypertension, hyperglycemia, and dyslipidemia, compared to the general population. Objective to determine the correlation between the total score of the Positive and Negative Syndrome Scale (PANSS) and High-Density Lipopretein-Cholesterol (HDL-C) levels in men with chronic schizophrenia. The sampling method is non-probability sampling with consecutive sampling type with a total of 77 people. Samples that meet the inclusion criteria and are willing to participate in further research, will be interviewed with the Mini International Neuropsychiatric Interview (MINI) ICD-10 (A1) version where the diagnosis is made using diagnostic guidelines based on PPDGJ-III. If they meet the criteria, they are asked to fill out the PANSS questionnaire. This analysis uses the Pearson Correlation. The results with the correlation test between HDL-C level and total PANSS score were tested using the Pearson test. From the results above, it was obtained p-value<0.001 which indicates that there is a very significant correlation between PANSS score and HDL-C level. The Pearson correlation value of r=-0.68 suggests a negative correlation with strong correlation strength, this indicates that the lower the HDL-C level, the higher the total PANSS score. We found a negative correlation with a strong correlation, this suggests that the lower the HDL-C level, the higher the total PANSS score.

References

Armstrong, M. K., Fraser, B. J., Hartiala, O., Buscot, M. J., Juonala, M., Wu, F., Koskinen, J., Hutri-Kähönen, N., Kähönen, M., Laitinen, T. P., Lehtimäki, T., Viikari, J. S. A., Raitakari, O. T. & Magnussen, C. G. (2021). Association of Non-High-Density Lipoprotein Cholesterol Measured in Adolescence, Young Adulthood, and Mid-Adulthood with Coronary Artery Calcification Measured in Mid-Adulthood. JAMA Cardiology, 6(6), 661–668. https://doi.org/10.1001/jamacardio.2020.7238

Bryll, A., Krzyściak, W., Karcz, P., Śmierciak, N., Kozicz, T., Skrzypek, J., Szwajca, M., Pilecki, M. & Popiela, T. J. (2020). The relationship between the level of anterior cingulate cortex metabolites, brain-periphery redox imbalance, and the clinical state of patients with schizophrenia and personality disorders. Biomolecules, 10(9), 1–33. https://doi.org/10.3390/biom10091272

Franczyk, B., Gluba-Brzózka, A., Ciałkowska-Rysz, A., Ławiński, J. & Rysz, J. (2023). The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review. International Journal of Molecular Sciences, 24(5). https://doi.org/10.3390/ijms24054653

Gogtay, N., Vyas, N. S., Testa, R., Wood, S. J. & Pantelis, C. (2011). Age of onset of schizophrenia: Perspectives from structural neuroimaging studies. Schizophrenia Bulletin, 37(3), 504–513. https://doi.org/10.1093/schbul/sbr030

González-Rodríguez, A., Seeman, M. V., Guàrdia, A., Natividad, M., Román, E., Izquierdo, E. & Monreal, J. A. (2023). A Review of Cardiovascular Risk Factors in Women with Psychosis. Women, 3(2), 200–213. https://doi.org/10.3390/women3020016

Gracianita, P., Pandia, V., Shelly Iskandar & Ghozal, M. (2020). Perbandingan Skor Positive and Negative Syndrome Scale Antara Skizofrenia Awitan Remaja dan Awitan Dewasa. Journal Of The Indonesian Medical Association, 70(8), 159–166. https://doi.org/10.47830/jinma-vol.70.8-2020-273

Harvey, P. D., Strassnig, M. T. & Silberstein, J. (2019). Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment. Journal of Experimental Psychopathology, 10(3). https://doi.org/10.1177/2043808719865693

Huang, H., Yang, B., Yu, R., Ouyang, W., Tong, J. & Le, Y. (2024). Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults. Nutrition Journal, 23(1), 1–9. https://doi.org/10.1186/s12937-024-00983-9

Kim, H. J., Jeong, S., Oh, Y. H., Park, S. J., Cho, Y. & Park, S. M. (2023). Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants. Cardiovascular Diabetology, 22(1), 1–10. https://doi.org/10.1186/s12933-023-01805-8

Li, R., Zhang, Y., Zhu, W., Ding, C., Dai, W., Su, X., Dai, W., Xiao, J., Xing, Z. & Huang, X. (2020). Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis. Scientific Reports, 10(1), 1–14. https://doi.org/10.1038/s41598-020-73983-4

Liu, C., Dhindsa, D., Almuwaqqat, Z., Ko, Y. A., Mehta, A., Alkhoder, A. A., Alras, Z., Desai, S. R., Patel, K. J., Hooda, A., Wehbe, M., Sperling, L. S., Sun, Y. V. & Quyyumi, A. A. (2022). Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations. JAMA Cardiology, 7(7), 672–680. https://doi.org/10.1001/jamacardio.2022.0912

Makary, S., Abd El Moez, K., Elsayed, M. & Hassan, H. (2023). Second-generation antipsychotic medications and metabolic disturbance in children and adolescents. Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 59(1). https://doi.org/10.1186/s41983-023-00612-y

Margariti, M. M. & Vlachos, I. I. (2022). The concept of psychotic arousal and its relevance to abnormal subjective experiences in schizophrenia. A hypothesis for the formation of primary delusions. Medical Hypotheses, 166(February), 110915. https://doi.org/10.1016/j.mehy.2022.110915

Mørland, J. G., Magnus, P., Vollset, S. E., Leon, D. A., Selmer, R. & Tverdal, A. (2023). Associations between serum high-density lipoprotein cholesterol levels and cause-specific mortality in a general population of 345 000 men and women aged 20–79 years. International Journal of Epidemiology, 52(4), 1257–1267. https://doi.org/10.1093/ije/dyad011

Sayed, S. El, Gomaa, S., Alhazmi, A., ElKalla, I. & Khalil, D. (2023). Metabolic profile in first episode drug naïve patients with psychosis and its relation to cognitive functions and social cognition: a case control study. Scientific Reports, 13(1), 1–12. https://doi.org/10.1038/s41598-023-31829-9

Sinott, R., Franco, A. L., Schimidt, F., Higuchi, C. H., de Araújo Filho, G. M., Bressan, R. A., Gadelha, A. & Ortiz, B. B. (2016). What do bizarre delusions mean in schizophrenia? Psychosis, 8(3), 270–276. https://doi.org/10.1080/17522439.2015.1100668

von Eckardstein, A., Nordestgaard, B. G., Remaley, A. T. & Catapano, A. L. (2023). High-density lipoprotein revisited: biological functions and clinical relevance. European Heart Journal, 44(16), 1394–1407. https://doi.org/10.1093/eurheartj/ehac605

Wu, T. Y., Tien, N., Lin, C. L., Cheah, Y. C., Hsu, C. Y., Tsai, F. J., Fang, Y. J. & Lim, Y. P. (2023). Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and in vitro hepatic lipid homeostasis gene expression. Frontiers in Medicine, 10(June), 1–14. https://doi.org/10.3389/fmed.2023.1137977

Xenaki, L. A., Stefanatou, P., Ralli, E., Hatzimanolis, A., Dimitrakopoulos, S., Soldatos, R. F., Vlachos, I. I., Selakovic, M., Foteli, S., Kosteletos, I., Nianiakas, N., Ntigridaki, A., Triantafyllou, T. F., Voulgaraki, M., Mantonakis, L., Tsapas, A., Bozikas, V. P., Kollias, K. & Stefanis, N. C. (2022). The relationship between early symptom severity, improvement and remission in first episode psychosis with jumping to conclusions. Schizophrenia Research, 240, 24–30. https://doi.org/10.1016/j.schres.2021.11.039